bluebird bio Presents Positive Long-Term Data On LYFGENIA Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology Annual Meeting and Exposition
LYFCX Fund | USD 12.99 0.15 1.17% |
Slightly above 50% of Alphacentric Lifesci's investors are presently thinking to get in. The analysis of overall sentiment of trading Alphacentric Lifesci Healthcare mutual fund suggests that some investors are interested at this time. Alphacentric Lifesci's investing sentiment can be driven by a variety of factors including economic data, Alphacentric Lifesci's earnings reports, geopolitical events, and overall market trends.
Alphacentric |
SOMERVILLE, Mass., December 08, 2024--bluebird bio, Inc. today announced new and updated data from LYFGENIA gene therapy for patients with sickle cell disease who have a history of vaso-occlusive events . The data will be presented at the 66th American Society of Hematology Annual Meeting and Exposition in an oral presentation on Sunday, December 8 at 930 a.m. Pacific Time and a poster presentation on Sunday, December 8 at 6
Read at finance.yahoo.com
![]() |
Alphacentric Lifesci Fundamental Analysis
We analyze Alphacentric Lifesci's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alphacentric Lifesci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alphacentric Lifesci based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Annual Yield
Annual Yield Comparative Analysis
Alphacentric Lifesci is currently under evaluation in annual yield among similar funds. Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Alphacentric Lifesci Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alphacentric Lifesci mutual fund to make a market-neutral strategy. Peer analysis of Alphacentric Lifesci could also be used in its relative valuation, which is a method of valuing Alphacentric Lifesci by comparing valuation metrics with similar companies.
Peers
Alphacentric Lifesci Related Equities
PLMPX | Pimco Emerging | 0.28 | ||||
IGIEX | Ashmore Emerging | 0.12 | ||||
BXECX | Barings Emerging | 0.13 | ||||
PIEFX | Pnc Emerging | 1.32 | ||||
REMVX | Rbc Emerging | 1.56 | ||||
EGLNX | Eagle Mlp | 1.61 | ||||
GAGPX | Goldman Sachs | 1.80 | ||||
JFAMX | Jpmorgan Emerging | 2.09 |
Other Information on Investing in Alphacentric Mutual Fund
Alphacentric Lifesci financial ratios help investors to determine whether Alphacentric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphacentric with respect to the benefits of owning Alphacentric Lifesci security.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |